Malignant Neuroendocrine Carcinoma clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
This is a pilot study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinoma
San Francisco, California and other locations
Our lead scientists for Malignant Neuroendocrine Carcinoma research studies include Emily Bergsland, MD.